InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
25
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Gv 2017 Gp, L.l.c.. Officer active across 2 companies, notably Verve Therapeutics, Inc.. In total, 54 filings have been recorded. Split: 0 buy · 25 sells. Total volume traded: €17.2m. History available since 31 October 2022. The latest transaction was filed on 27 July 2026 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gv 2017 Gp, L.l.c.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations54 total
118,138 shares0Class A Common StockSEC:0001168404-26-000041:2
196,931 shares0Class A Common StockSEC:0001168404-26-000041:0
196,931 shares@ US$19.46290.21% mcap32.9% of flowClass A Common StockSEC:0001168404-26-000041:1
118,138 shares@ US$18.89960.12% mcap19.2% of flowClass A Common StockSEC:0001168404-26-000041:3
63,297 shares0Class A Common StockSEC:0001168404-26-000039:0
23,417 shares@ US$18.87527.9% of flowClass A Common StockSEC:0001168404-26-000039:3
63,297 shares@ US$19.057321.5% of flowClass A Common StockSEC:0001168404-26-000039:1
23,417 shares0Class A Common StockSEC:0001168404-26-000039:2
49,582 shares0Class A Common StockSEC:0001168404-26-000036:3
200 shares@ US$19.720.1% of flowClass A Common StockSEC:0001168404-26-000036:2
49,582 shares@ US$19.230124.2% of flowClass A Common StockSEC:0001168404-26-000036:4
22,700 shares@ US$19.049511.0% of flowClass A Common StockSEC:0001168404-26-000036:1
22,900 shares0Class A Common StockSEC:0001168404-26-000036:0
18,386 shares@ US$18.865413.5% of flowClass A Common StockSEC:0001168404-26-000031:3
20,534 shares0Class A Common StockSEC:0001168404-26-000031:0
18,386 shares0Class A Common StockSEC:0001168404-26-000031:2
20,534 shares@ US$18.681915.0% of flowClass A Common StockSEC:0001168404-26-000031:1
74,492 shares0Class A Common StockSEC:0001168404-26-000029:0
19,595 shares@ US$18.729720.0% of flowClass A Common StockSEC:0001168404-26-000029:4
12,500 shares@ US$18.79312.8% of flowClass A Common StockSEC:0001168404-26-000029:1
61,992 shares@ US$19.837667.2% of flowClass A Common StockSEC:0001168404-26-000029:2
19,595 shares0Class A Common StockSEC:0001168404-26-000029:3
1,755,632 sharesClass A Common StockSEC:0001168404-26-000007:0
6,108,442 sharesCommon StockSEC:0001415889-25-020384:0
37,405 shares0Common StockSEC:0001209191-23-039122:0
25 of 54 declarations
About Gv 2017 Gp, L.l.c.
GV 2017 GP, L.L.C. is a declarant linked to Verve Therapeutics, Inc. and Ethos Technologies Inc.. It has filed 12 filings in total, and across the 12 recent sampled filings the transactions are sales for a total of EUR 3103308, with the first filing on 2021-06-22 and the last on 2026-01-30.
